At micromolar concentrations, many small molecules self-associate into colloidal aggregates that non-specifically inhibit enzymes and other proteins. Here we describe a protocol for identifying aggregate-based inhibitors and distinguishing them from small molecules that inhibit via specific mechanisms. As a convenient proxy for promiscuous, aggregate-based inhibition, we monitor inhibition of β-lactamase in the absence and presence of detergent. Inhibition that is attenuated in the presence of detergent is characteristic of an aggregate-based mechanism. In the 96-well-format assay described here, about 200 molecules can be tested, in duplicate, per hour for detergent-dependent sensitivity. Furthermore, we also describe simple experiments th...
Small molecule colloidal aggregates adsorb and partially denature proteins, inhibiting them artifact...
Small molecule effectors are essential for drug discovery. Specific molecular recognition, reversibl...
Molecules that disrupt protein aggregation represent potential tool compounds for the investigation ...
In the early phases of drug discovery, high-throughput screening (HTS) has emerged as the dominant t...
High-throughput screening (HTS) is the primary technique for new lead identification in drug discove...
Early drug discovery is plagued by nonspecific molecules, which cannot be developed into drugs. Thes...
One of the leading sources of false positives in early drug discovery is the formation of organic sm...
Small-molecule aggregates are a leading cause of artifacts in early drug discovery, but little is kn...
One of the leading sources of false positives in early drug discovery is the formation of organic sm...
Abstract: Screening in mixtures is a common approach for increasing the efficiency of high-throughpu...
Abstract: It is recognized that high-throughput enzyme inhibition screens often return nonspecific i...
Protein aggregation underlies an array of human diseases, yet only one small molecule therapeutic ha...
High-throughput and virtual screening are widely used to discover novel leads for drug design. On ex...
Drug discovery is fuelled by small-molecules, either as tools to interrogate biology or as leads for...
Traditional Chinese Medicines (TCMs) have been the sole source of therapeutics in China for two mill...
Small molecule colloidal aggregates adsorb and partially denature proteins, inhibiting them artifact...
Small molecule effectors are essential for drug discovery. Specific molecular recognition, reversibl...
Molecules that disrupt protein aggregation represent potential tool compounds for the investigation ...
In the early phases of drug discovery, high-throughput screening (HTS) has emerged as the dominant t...
High-throughput screening (HTS) is the primary technique for new lead identification in drug discove...
Early drug discovery is plagued by nonspecific molecules, which cannot be developed into drugs. Thes...
One of the leading sources of false positives in early drug discovery is the formation of organic sm...
Small-molecule aggregates are a leading cause of artifacts in early drug discovery, but little is kn...
One of the leading sources of false positives in early drug discovery is the formation of organic sm...
Abstract: Screening in mixtures is a common approach for increasing the efficiency of high-throughpu...
Abstract: It is recognized that high-throughput enzyme inhibition screens often return nonspecific i...
Protein aggregation underlies an array of human diseases, yet only one small molecule therapeutic ha...
High-throughput and virtual screening are widely used to discover novel leads for drug design. On ex...
Drug discovery is fuelled by small-molecules, either as tools to interrogate biology or as leads for...
Traditional Chinese Medicines (TCMs) have been the sole source of therapeutics in China for two mill...
Small molecule colloidal aggregates adsorb and partially denature proteins, inhibiting them artifact...
Small molecule effectors are essential for drug discovery. Specific molecular recognition, reversibl...
Molecules that disrupt protein aggregation represent potential tool compounds for the investigation ...